Global Adoptive Cell Therapy Market Overview:
Global Adoptive Cell Therapy Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2024 as the base year.
Global Adoptive Cell Therapy Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Adoptive Cell Therapy involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Adoptive Cell Therapy Market:
The Adoptive Cell Therapy Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Adoptive Cell Therapy Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Adoptive Cell Therapy Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Adoptive Cell Therapy market has been segmented into:
CAR-T
TCR-T
NK
and TIL
By Application, Adoptive Cell Therapy market has been segmented into:
Lymphoma
Leukemia
and Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Adoptive Cell Therapy market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Adoptive Cell Therapy market.
Top Key Players Covered in Adoptive Cell Therapy market are:
Novartis AG
Gilead Sciences
Inc.
Castle Creek Biosciences
Inc.
Lineage Cell Therapeutics
Inc.
Transgene SA
Cellectis
ImmunityBio
Inc.
Sorrento Therapeutics
bluebird bio
Inc.
Arcellx
Sana Biotechnology
Inc.
Biodesix
Inc
Laurus Labs
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Adoptive Cell Therapy Market by Type
4.1 Adoptive Cell Therapy Market Snapshot and Growth Engine
4.2 Adoptive Cell Therapy Market Overview
4.3 CAR-T
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 CAR-T: Geographic Segmentation Analysis
4.4 TCR-T
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 TCR-T: Geographic Segmentation Analysis
4.5 NK
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 NK: Geographic Segmentation Analysis
4.6 and TIL
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 and TIL: Geographic Segmentation Analysis
Chapter 5: Adoptive Cell Therapy Market by Application
5.1 Adoptive Cell Therapy Market Snapshot and Growth Engine
5.2 Adoptive Cell Therapy Market Overview
5.3 Lymphoma
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Lymphoma: Geographic Segmentation Analysis
5.4 Leukemia
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Leukemia: Geographic Segmentation Analysis
5.5 and Others
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 and Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Adoptive Cell Therapy Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 NOVARTIS AG
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 GILEAD SCIENCES
6.4 INC.
6.5 CASTLE CREEK BIOSCIENCES
6.6 INC.
6.7 LINEAGE CELL THERAPEUTICS
6.8 INC.
6.9 TRANSGENE SA
6.10 CELLECTIS
6.11 IMMUNITYBIO
6.12 INC.
6.13 SORRENTO THERAPEUTICS
6.14 BLUEBIRD BIO
6.15 INC.
6.16 ARCELLX
6.17 SANA BIOTECHNOLOGY
6.18 INC.
6.19 BIODESIX
6.20 INC
6.21 AND LAURUS LABS
Chapter 7: Global Adoptive Cell Therapy Market By Region
7.1 Overview
7.2. North America Adoptive Cell Therapy Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 CAR-T
7.2.4.2 TCR-T
7.2.4.3 NK
7.2.4.4 and TIL
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Lymphoma
7.2.5.2 Leukemia
7.2.5.3 and Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Adoptive Cell Therapy Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 CAR-T
7.3.4.2 TCR-T
7.3.4.3 NK
7.3.4.4 and TIL
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Lymphoma
7.3.5.2 Leukemia
7.3.5.3 and Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Adoptive Cell Therapy Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 CAR-T
7.4.4.2 TCR-T
7.4.4.3 NK
7.4.4.4 and TIL
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Lymphoma
7.4.5.2 Leukemia
7.4.5.3 and Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Adoptive Cell Therapy Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 CAR-T
7.5.4.2 TCR-T
7.5.4.3 NK
7.5.4.4 and TIL
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Lymphoma
7.5.5.2 Leukemia
7.5.5.3 and Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Adoptive Cell Therapy Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 CAR-T
7.6.4.2 TCR-T
7.6.4.3 NK
7.6.4.4 and TIL
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Lymphoma
7.6.5.2 Leukemia
7.6.5.3 and Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Adoptive Cell Therapy Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 CAR-T
7.7.4.2 TCR-T
7.7.4.3 NK
7.7.4.4 and TIL
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Lymphoma
7.7.5.2 Leukemia
7.7.5.3 and Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Adoptive Cell Therapy Scope:
|
Report Data
|
Adoptive Cell Therapy Market
|
|
Adoptive Cell Therapy Market Size in 2025
|
USD XX million
|
|
Adoptive Cell Therapy CAGR 2025 - 2032
|
XX%
|
|
Adoptive Cell Therapy Base Year
|
2024
|
|
Adoptive Cell Therapy Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Novartis AG, Gilead Sciences, Inc., Castle Creek Biosciences, Inc., Lineage Cell Therapeutics, Inc., Transgene SA, Cellectis, ImmunityBio, Inc., Sorrento Therapeutics, bluebird bio, Inc., Arcellx, Sana Biotechnology, Inc., Biodesix, Inc, and Laurus Labs.
|
|
Key Segments
|
By Type
CAR-T
TCR-T
NK
and TIL
By Applications
Lymphoma
Leukemia
and Others
|
